Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Liver cancer risk reduced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment

People who are cured of hepatitis C after a course of direct-acting antiviral (DAA) treatment do not have a higher risk of developing liver cancer (hepatocellular carcinoma),

Published
14 November 2016
By
Keith Alcorn
Smoking more harmful than HIV for people taking effective treatment, US study suggests

Smoking has the potential to shorten the life of a person taking HIV treatment by an average of six years, and is far more harmful to

Published
08 November 2016
By
Keith Alcorn
HIV, HPV and cervical cancer—leveraging synergies to save women’s lives

Leveraging the experience and innovative activism of more than three decades of the AIDS response, Mr Sidibé called for greater mobilization and the breaking down of silos between programmes and services to deliver comprehensive sexual and reproductive health services for women and girls.

Published
02 November 2016
From
UNAIDS
Only a small proportion of gay men with HIV receive anal cancer screening

In the absence of national screening guidelines, only 11% of HIV-positive gay and bisexual men in the US received anal pap smears to detect anal cancer or

Published
31 October 2016
By
Liz Highleyman
We could prevent millions of cancer deaths with knowledge we already have

Cutting-edge breakthroughs are still vital in medicine, but we have many ways to prevent and cure cancer that aren’t globally accessible – but should be.

Published
18 October 2016
From
The Guardian
Less than 100% adherence to HIV therapy, even with viral suppression, can lead to more inflammation and immune activation

Research involving men taking antiretroviral therapy, all with an undetectable viral load, has shown that imperfect adherence to therapy is associated with higher levels of key markers of

Published
12 October 2016
By
Michael Carter
No evidence that contaminated nelfinavir led to increased risk of birth abnormalities or cancer

HIV-negative infants potentially exposed in utero to doses of the HIV protease inhibitor nelfinavir (Viracept) contaminated with the toxic compound ethyl methyl sulfone (EMS) did not have an

Published
10 October 2016
By
Michael Carter
I wrote this piece while getting chemotherapy, because people have started using cancer patients like me as a weapon against gay people

Patient needs should never be pitted against each other and, as a cancer patient and gay man, I see the importance of both my chemotherapy and the need for PrEP as non-paralleled treatments that cannot be compared against each other.

Published
19 September 2016
From
The Independent
Managing non-communicable diseases among people living with HIV

Non-communicable diseases (NCDs) – including cardiovascular diseases, diabetes, cancers, and other illnesses – will represent a significant challenge for HIV care in low- and middle-income countries as

Published
13 September 2016
By
Theo Smart
A closer look at cancer among people living with HIV

Since the roll-out of combination antiretroviral therapy, cancer trends for people living with HIV have been changing. Rates of some cancers, like Kaposi sarcoma—have decreased. Others, however, including anal cancer, have actually gone up in recent years. What’s going on—and what should people living with HIV know about their risk for cancer as they grow older?

Published
01 September 2016
From
BETA blog
← First12345...41Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.